Akero Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Akero Therapeutics's estimated annual revenue is currently $5.4M per year.
- Akero Therapeutics's estimated revenue per employee is $75,347
- Akero Therapeutics's current valuation is $776.6M. (January 2022)
Employee Data
- Akero Therapeutics has 72 Employees.
- Akero Therapeutics grew their employee count by 44% last year.
Akero Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO and Head Corporate Development | Reveal Email/Phone |
2 | SVP, Commercial Strategy | Reveal Email/Phone |
3 | VP, FP&A | Reveal Email/Phone |
4 | VP, Head Regulatory Affairs | Reveal Email/Phone |
5 | VP, Clinical Research and Medical Affairs | Reveal Email/Phone |
6 | VP Quality Assurance | Reveal Email/Phone |
7 | EVP and COO | Reveal Email/Phone |
8 | VP, Process Development | Reveal Email/Phone |
9 | VP Finance | Reveal Email/Phone |
10 | EVP and Chief Development Officer | Reveal Email/Phone |
Akero Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Akero Therapeutics?
Akero Therapeutics is developing best-in-class medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases. Akero's lead clinical program, AKR-001, is a long-acting Fc fusion modified FGF21 protein and potential best-in-class treatment for NASH. AKR-001 builds upon two decades of work on FGF21 biology. It is designed to affect both the liver and adipose tissue, reducing liver fat and suppressing inflammation and fibrosis.
keywords:N/A
N/A
Total Funding
72
Number of Employees
$5.4M
Revenue (est)
44%
Employee Growth %
$776.6M
Valuation
N/A
Accelerator
Akero Therapeutics News
2022-03-22 - Akero Therapeutics Reports Fourth Quarter and Full Year ...
Akero Therapeutics is a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by...
Other Companies in South San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15M | 72 | 0% | N/A |
#2 | $19.1M | 73 | 4% | N/A |
#3 | $5.7M | 74 | 19% | $188.9M |
#4 | $18.9M | 77 | 10% | N/A |
#5 | $23.5M | 77 | 12% | N/A |